Always Smile With Daewoong

home Home > About Us > Press Release > News

뉴스
No	Subject	Data
225	Daewoong Pharmaceuticals holds a symposium to promote the excellence of Olmesartan medications including ‘Olmetec’ at International Society of Hypertension	2016-09-28
224	Daewoong Pharmaceuticals expands entry to new markets with license in Mexico and India on Nabota	2016-09-22
223	Daewoong Pharmaceuticals disseminates the excellence of ‘Nabota’ in IMCAS	2016-08-02
222	Daewoong Pharmaceuticals signs 29 billion won export contract with Jordan and Iraq	2016-06-30
221	Seoul National University Hospital ? Daewoong Pharmaceuticals sign MOU to commercialize stem cell treatment	2016-06-28
220	Daewoong Pharmaceuticals presents result of phase 3 clinical trial on Supect at The Korean Society of Hematology	2016-05-31
219	Daewoong Pharmaceuticals receives Prime Minister Commendation as an ‘Outstanding Company in Fair Gender Employment’	2016-05-26
218	Daewoong Bio ‘UDCA’ passes EDQM (European Directorate for the Quality of Medicines & Healthcare) inspection	2016-05-26
217	Daewoong Pharmaceuticals invites public officials in drug safety management from 11 countries to its Hyangnam Plant	2016-05-26
216	Daewoong Pharmaceuticals’ Zemiglo increases quarterly sales by twofold compared to last year	2016-05-26

1 / 2 / 3 / 4 / 5 / 6 / 7 / 8 / 9 / 10 /